78040636 - BITE

Information

• Trademark
• 78040636

• Source

• Serial Number

  78040636

• Registration Number

  3068856

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 26, 2000
  24 years ago

• Registration Date

  March 14, 2006
  19 years ago

• Transaction Date

  March 15, 2025
  17 days ago

• Status Date

  June 28, 2016
  8 years ago

• Published for Opposition Date

  September 09, 2003
  21 years ago

• Renewal Date

  March 14, 2016
  9 years ago

• Location Date

  June 28, 2016
  8 years ago

• First Use Anywhere Date

  November 01, 2001
  23 years ago

• First Use In Commerce Date

  November 01, 2001
  23 years ago

• Status Code

  800

• Current Location

  TMO LAW OFFICE 112

  Employee Name

  BLANDU, FLORENTINA

• Attorney Docket Number

  TM-1048-US-1

  Attorney Name

  Elsa D. Lemoine

  Law Office Assigned Location Code

  M30

• Owners

  • MICROMET GMBH

Case File Statements

• GS0051: [ Medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intra-peritoneal, intra-muscular and aerosol therapies ]
• CC0000: Color is not claimed as a feature of the mark.
• GS0351: [ Human and veterinary services, namely, licensing of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases; licensing of technology for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells ]
• GS0421: Medical services; laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; human and veterinary services, namely, product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells

Case File Event Statements

• 2/14/2002 - 23 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/17/2001 - 23 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK

• 6/6/2001 - 23 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 11/29/2001 - 23 years ago

  3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/4/2002 - 23 years ago

  4 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 2/5/2002 - 23 years ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/24/2003 - 21 years ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/10/2002 - 22 years ago

  7 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 4/10/2002 - 22 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/9/2002 - 22 years ago

  9 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 6/26/2002 - 22 years ago

  10 - NON-FINAL ACTION MAILED Type: CNRT

• 10/21/2002 - 22 years ago

  11 - PAPER RECEIVED Type: MAIL

• 10/21/2002 - 22 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/6/2003 - 22 years ago

  13 - NON-FINAL ACTION MAILED Type: CNRT

• 5/22/2003 - 21 years ago

  14 - PAPER RECEIVED Type: MAIL

• 5/22/2003 - 21 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/20/2003 - 21 years ago

  17 - NOTICE OF PUBLICATION Type: NPUB

• 11/29/2004 - 20 years ago

  26 - SOU EXTENSION 2 FILED Type: EXT2

• 9/9/2003 - 21 years ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/29/2003 - 21 years ago

  19 - PAPER RECEIVED Type: MAIL

• 12/2/2003 - 21 years ago

  20 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/19/2004 - 20 years ago

  21 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/19/2004 - 20 years ago

  23 - SOU EXTENSION 1 FILED Type: EXT1

• 5/28/2004 - 20 years ago

  24 - SOU EXTENSION 1 GRANTED Type: EX1G

• 5/26/2004 - 20 years ago

  22 - CASE FILE IN TICRS Type: CFIT

• 11/29/2004 - 20 years ago

  25 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/8/2004 - 20 years ago

  27 - SOU EXTENSION 2 GRANTED Type: EX2G

• 2/1/2006 - 19 years ago

  35 - ASSIGNED TO LIE Type: ALIE

• 2/1/2006 - 19 years ago

  36 - LAW OFFICE REGISTRATION REVIEW COMPLETED Type: REGV

• 3/14/2006 - 19 years ago

  37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/19/2005 - 19 years ago

  28 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/19/2005 - 19 years ago

  29 - SOU EXTENSION 3 FILED Type: EXT3

• 6/3/2005 - 19 years ago

  30 - SOU EXTENSION 3 GRANTED Type: EX3G

• 12/2/2005 - 19 years ago

  32 - USE AMENDMENT FILED Type: IUAF

• 12/27/2005 - 19 years ago

  33 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 12/5/2005 - 19 years ago

  31 - PAPER RECEIVED Type: MAIL

• 1/17/2006 - 19 years ago

  34 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 3/14/2015 - 10 years ago

  43 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 6/28/2016 - 8 years ago

  46 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 6/18/2011 - 13 years ago

  38 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 3/1/2012 - 13 years ago

  39 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 3/31/2012 - 13 years ago

  40 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 4/1/2012 - 13 years ago

  41 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A

• 4/2/2012 - 13 years ago

  42 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 3/23/2016 - 9 years ago

  44 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 4/8/2016 - 8 years ago

  45 - TEAS SECTION 8 & 9 RECEIVED Type: E89R

• 6/28/2016 - 8 years ago

  47 - REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED Type: 8PRT

• 6/28/2016 - 8 years ago

  48 - REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 Type: 9G8P

• 6/28/2016 - 8 years ago

  49 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1

• 6/28/2016 - 8 years ago

  50 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8

• 8/2/2018 - 6 years ago

  51 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/2/2018 - 6 years ago

  52 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 3/7/2019 - 6 years ago

  53 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 3/7/2019 - 6 years ago

  54 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 4/29/2022 - 2 years ago

  55 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 4/29/2022 - 2 years ago

  57 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 4/29/2022 - 2 years ago

  59 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR

• 4/29/2022 - 2 years ago

  61 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 4/29/2022 - 2 years ago

  60 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/29/2022 - 2 years ago

  56 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/29/2022 - 2 years ago

  58 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 3/14/2025 - 18 days ago

  62 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2